Not applicableStudy completedNCT07201831
What this trial is testing
A Multi-country, Cross-sectional Quantitative Study Exploring Awareness, Understanding, and Perceptions of the Relation Between Cardiorenal Metabolic Conditions and MASLD/MASH Among Healthcare Providers, People With MASLD/MASH, and At-risk Population
Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis (MASH)
Novo Nordisk A/S 1,330